FormFactor (FORM) Up 4% Since Last Earnings Report: Can It Continue?

FormFactor (FORM) reported mixed second-quarter 2025 results, with non-GAAP EPS of 27 cents surpassing estimates despite a 23% year-over-year decline, and revenues of $195.8 million also beating expectations but decreasing 0.9% YoY. The company experienced significant gross margin contraction to 38.5% and negative free cash flow of $47.1 million. While shares have gained 4% since the report, analyst estimates for future quarters have since trended sharply downward by nearly 27%, leading to a Zacks Rank #4 (Sell) and an outlook for below-average returns despite the stock's recent outperformance.

Analysis

FormFactor's second-quarter 2025 results present a conflicting picture where headline beats on earnings and revenue mask significant underlying fundamental deterioration. While non-GAAP EPS of 27 cents surpassed estimates by 10% and revenue of $195.8 million beat by 2.87%, both metrics declined year-over-year by 23% and 0.9% respectively. Profitability is a major concern, evidenced by a severe 680 basis point contraction in gross margin to 38.5% and a 280 bps drop in the non-GAAP operating margin. The balance sheet weakened, with a negative free cash flow of $47.1 million and a sequential decline in cash reserves. Geographically, the business saw a dramatic revenue collapse in China (-62.5% YoY) and the United States (-14.6% YoY), which was not fully offset by growth in Taiwan and Japan. Despite the stock's 4% gain since the report, a strong bearish signal has emerged from analysts, who have slashed consensus estimates by nearly 27%, leading to a Zacks Rank #4 (Sell) and a poor overall VGM Score of D. The company's Q3 guidance for a lower EPS of 25 cents further tempers any optimism from the modest sequential revenue growth projection.

Key Decisions for Investors

• Investors should treat the recent 4% share price appreciation with caution, as it appears disconnected from the reality of declining year-over-year earnings, severe margin compression, and negative free cash flow.
• The sharp 26.95% downward revision in analyst consensus estimates is a significant leading indicator of future underperformance, suggesting the backward-looking Q2 earnings beat is unlikely to sustain positive momentum.
• Consider reducing exposure or hedging positions, as the combination of a Zacks #4 (Sell) rank, deteriorating fundamentals, and a significant revenue collapse of 62.5% in the key China market points to heightened risk in the near term.